Maternal insulin-like growth factor binding protein-1, body mass index, and fetal growth
Authors:
Open Access
- 1 March 2000
- journal article
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 82 (2) , F113-F117
Abstract
AIM To examine the hypothesis that the maternal insulin-like growth factor system may constrain fetal growth. METHODS A prospective observational study of maternal serum insulin-like growth factor binding protein-1 (IGFBP-1) and fetal growth was undertaken in neonates with birthweights below the 5th centile. They had been classified either as having fetal growth restriction (FGR) due to placental dysfunction (increased umbilical artery Doppler pulsatility index (PI); n = 25) or as being small for gestational age (SGA; normal umbilical artery PI, growth velocity and amniotic fluid; n = 27). Eighty nine controls had normal birthweights (5th–95th centile), umbilical artery PI, growth velocity, and amniotic fluid. IGFBP-1 was measured by radioimmunoassay. RESULTS Among the controls, there was no significant correlation between IGFBP-1 and birthweight after allowing for body mass index (BMI). Maternal BMI was high in FGR and after adjusting for this, IGFBP-1 was increased (109 ng/ml) compared with SGA babies (69 ng/ml) and controls (57 ng/ml) and correlated with the umbilical artery PI. CONCLUSIONS Maternal IGFBP-1 is probably not part of normal placental function. Its increase in FGR could be the cause or consequence of impaired placental perfusion, but high IGFBP-1 concentrations might further reduce the availability of maternal IGF-I to the placenta. This could worsen placental function and so adversely affect fetal growth. Key messages Maternal insulin-like growth factor-1 (IGFBP-1) does not correlate with birthweight in normal pregnancy but concentrations are increased in fetal growth restriction (FGR) Maternal body mass index is an important confounder when assessing the relation between maternal IGFBP-1 and fetal growth Increased maternal IGFBP-1 in FGR may further reduce availability to the placenta of already low concentrations of IGFBP-1 Normal maternal IGFBP-1 concentrations in small for gestational age pregnancies indicates the use of umbilical artery Doppler to assess placental function when fetal size is <5th centile for gestational ageKeywords
This publication has 30 references indexed in Scilit:
- Small for gestational age is not a diagnosisUltrasound in Obstetrics & Gynecology, 1999
- The relationship between insulin sensitivity and insulin-like growth factor-binding protein-1Gynecological Endocrinology, 1996
- Lack of evidence for a circadian rhythm of IGFBP‐1 in the mother and fetus during labourBJOG: An International Journal of Obstetrics & Gynaecology, 1995
- Maternal carbohydrate metabolism and its relationship fetal growth and body compositionAmerican Journal of Obstetrics and Gynecology, 1995
- The pathophysiology of the insulin‐like growth factor axis in fetal growth failure: a basis for programming by undernutrition?European Journal of Clinical Investigation, 1994
- Prediction of morbidity in small and normally grown fetuses by fetal heart rate variability, biophysical profile score and umbilical artery Doppler studiesBJOG: An International Journal of Obstetrics & Gynaecology, 1993
- Suppression of endogenous insulin secretion regulates the rapid rise of insulin‐like growth factor binding protein (IGFBP)‐1 levels following acute hypoglycaemiaClinical Endocrinology, 1993
- Levels of insulin‐like growth factor‐I and insulin‐like growth factor‐binding protein‐1 in pregnancy with preterm deliveryBJOG: An International Journal of Obstetrics & Gynaecology, 1993
- Insulin-like growth factor-binding protein-1, glucose tolerance and fetal growth in human pregnancyJournal of Endocrinology, 1993
- Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlationBJOG: An International Journal of Obstetrics & Gynaecology, 1985